JP4820192B2 - 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 - Google Patents

急性冠症候群でのａｄａｍｔｓ１３の測定と利用 Download PDF

Info

Publication number
JP4820192B2
JP4820192B2 JP2006075498A JP2006075498A JP4820192B2 JP 4820192 B2 JP4820192 B2 JP 4820192B2 JP 2006075498 A JP2006075498 A JP 2006075498A JP 2006075498 A JP2006075498 A JP 2006075498A JP 4820192 B2 JP4820192 B2 JP 4820192B2
Authority
JP
Japan
Prior art keywords
adamts13
amount
vwf
patients
myocardial infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2006075498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007248395A (ja
JP2007248395A5 (enExample
Inventor
久雄 小川
幸一 海北
将三 松川
見事 副島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP2006075498A priority Critical patent/JP4820192B2/ja
Publication of JP2007248395A publication Critical patent/JP2007248395A/ja
Publication of JP2007248395A5 publication Critical patent/JP2007248395A5/ja
Application granted granted Critical
Publication of JP4820192B2 publication Critical patent/JP4820192B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2006075498A 2006-03-17 2006-03-17 急性冠症候群でのａｄａｍｔｓ１３の測定と利用 Active JP4820192B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006075498A JP4820192B2 (ja) 2006-03-17 2006-03-17 急性冠症候群でのａｄａｍｔｓ１３の測定と利用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006075498A JP4820192B2 (ja) 2006-03-17 2006-03-17 急性冠症候群でのａｄａｍｔｓ１３の測定と利用

Publications (3)

Publication Number Publication Date
JP2007248395A JP2007248395A (ja) 2007-09-27
JP2007248395A5 JP2007248395A5 (enExample) 2009-04-23
JP4820192B2 true JP4820192B2 (ja) 2011-11-24

Family

ID=38592839

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006075498A Active JP4820192B2 (ja) 2006-03-17 2006-03-17 急性冠症候群でのａｄａｍｔｓ１３の測定と利用

Country Status (1)

Country Link
JP (1) JP4820192B2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10858689B2 (en) 2016-10-11 2020-12-08 Laboratory Corporation Of America Holdings Methods and systems for determining ADAMTS13 enzyme activity

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2685697T3 (es) 2002-05-09 2018-10-10 The Brigham And Women's Hospital, Inc. 1L1RL-1 como un marcador de enfermedades cardiovasculares
ATE527544T1 (de) 2006-04-24 2011-10-15 Critical Care Diagnostics Inc Vorhersage von letalität und detektion von schweren erkrankungen
EP2021796B1 (en) 2006-05-01 2012-02-08 Critical Care Diagnostics, Inc. Diagnosis of cardiovascular disease
EP2374878B1 (en) 2007-06-22 2015-08-19 The Chemo-Sero-Therapeutic Research Institute Novel adamts-13 mutant
PT2269063E (pt) 2008-04-18 2013-11-27 Critical Care Diagnostics Inc Predição do risco de eventos cardíacos adversos maiores
JP6111016B2 (ja) 2008-12-05 2017-04-05 バクスアルタ ゲーエムベーハー フォンビルブランド因子のａｄａｍｔｓ１３媒介インビボ切断を測定する方法およびその使用
JP5715137B2 (ja) * 2009-08-31 2015-05-07 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 主要有害心イベントの予測のためのバイオマーカーおよびその使用
HK1212057A1 (en) 2012-08-21 2016-06-03 重症监护诊断股份有限公司 Multimarker risk stratification
CN106066401B (zh) * 2014-03-07 2018-11-23 重庆早柒天生物科技股份有限公司 生物标志物vwf和adamts13及其在肝硬化诊断试剂中的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529373A (ja) * 1998-10-23 2002-09-10 ザ ブリガム アンド ウィメンズ ホスピタル，インコーポレイテッド コンホメーション特異的抗ｖｏｎＷｉｌｌｅｂｒａｎｄ因子抗体
JP4666942B2 (ja) * 2003-04-25 2011-04-06 学校法人慶應義塾 フォンビルブラント因子切断酵素遺伝子解析による血栓性疾患関連の遺伝子変異検出方法
WO2005008241A1 (en) * 2003-07-07 2005-01-27 University Of North Carolina At Chapel Hill Method and system for detection of von willebrand factor (vwf) multimers
JP4398188B2 (ja) * 2003-07-09 2010-01-13 積水メディカル株式会社 急性冠症候群およびその病態の検査方法
WO2005062054A1 (ja) * 2003-12-22 2005-07-07 Mitsubishi Kagaku Iatron, Inc. フォンヴィルブランド因子分解酵素の測定による血栓症の検出方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10858689B2 (en) 2016-10-11 2020-12-08 Laboratory Corporation Of America Holdings Methods and systems for determining ADAMTS13 enzyme activity
US11959124B2 (en) 2016-10-11 2024-04-16 Laboratory Corporation Of America Holdings Methods and systems for determining ADAMTS13 enzyme activity
US12442030B2 (en) 2016-10-11 2025-10-14 Laboratory Corporation Of America Holdings Methods and systems for determining ADAMTS13 enzyme activity

Also Published As

Publication number Publication date
JP2007248395A (ja) 2007-09-27

Similar Documents

Publication Publication Date Title
Twerenbold et al. High-sensitive troponin T measurements: what do we gain and what are the challenges?
Panteghini et al. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage
Kavsak et al. The impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction
Qin et al. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes
Panteghini et al. Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes
Harris et al. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures
Cervellin et al. Highly sensitive troponin immunoassays: navigating between the scylla and charybdis
Sayre et al. Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain
Scirica et al. Troponins in acute coronary syndromes
EP2047276A2 (en) Method for the prediction of vascular events and the diagnosis of acute coronary syndrome
Miyamoto et al. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina
EP1990421B1 (en) Method of detecting condition in patient with disturbance of consciousness
Eggers et al. Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain—an evaluation with respect to the Universal Definition of Myocardial Infarction
JP4820192B2 (ja) 急性冠症候群でのａｄａｍｔｓ１３の測定と利用
Luxembourg et al. Cardiovascular risk factors in idiopathic compared to riskassociated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP)
Wang et al. Red cell distribution width is increased in chronic thromboembolic pulmonary hypertension
Sylvén et al. Excellent reliability of nurse-based bedside diagnosis of acute myocardial infarction by rapid dry-strip creatine kinase MB, myoglobin, and troponin T
Collinson et al. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria
Gil et al. Plasma fibrinogen and troponin I in acute coronary syndrome and stable angina
Casals et al. Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction
Wu Use of cardiac markers as assessed by outcomes analysis
Nørgaard et al. Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring
KR20190088181A (ko) 뇌졸중 진단 또는 예후예측용 바이오마커 및 이의 용도
Wu Introduction to coronary artery disease (CAD) and biochemical markers
EP3730942A1 (en) Diagnosis markers for atrial fibrillation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090311

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110210

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110420

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110823

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110902

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140909

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4820192

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250